The primary mission of the Double H Ranch is to provide specialized camping and year round services for children and families dealing with life-threatening illnesses in order to enrich their lives and provide experiences that are memorable, empowering, fun, physically safe and medically sound while offered in a magical Adirondack setting. There is no charge for any of the Ranch’s programs. Program participants are only asked to provide their own transportation to and from the Ranch.
Our goal has always been to help families enjoy all the wonderful things that childhood has to offer. With the daily stress of living with diabetes we want to be able to provide a haven for families to take a breath and enjoy time with their family and an opportunity to make friends. We understand the high cost of diabetes and the many life changes that occur and wanted to truly support an organization that offers our families the ability to spend 2 nights and 3 days in a beautiful setting with wonderful friends and lots of activities. The Double H Ranch is that place. We would like to offer 15 families the ability to come to this ranch and have fun and make friends.
The entire camp experience is free. Campers must however provide their own transportation. We will be accepting recommendations starting April 27, 2010 with families being notified in December of 2010. We will also select 5 alternate families should something occur that enables a family to attend.
Biocon Announces Positive Results from its Phase 1 Comparative PK-PD Study with Biosimilar Insulin Glargine Bengaluru, Karnataka, India, Wednesday, July 25, 2012 -- (Business Wire India)
Biocon, Asia's premier biotechnology company, today announced positive results from a Phase 1 comparative study conducted in Germany of its Biosimilar Insulin Glargine in Type 1 Diabetes Mellitus (T1DM) patients.
This randomized, double-blind, euglycemic clamp study was conducted in T1DM patients to evaluate pharmacokinetic (PK) and pharmacodynamic (PD) equivalence of Biocon’s Insulin Glargine against the innovator product (Lantus®). The trial met all its primary and secondary endpoints.
These encouraging results indicate that Biocon’s Insulin Glargine is equivalent to the innovator product in terms of PK and PD. These robust clinical data along with extensive physicochemical and biological characterization data generated to date between Biocon’s Insulin Glargine and the innovator product will enable Biocon to start its Phase 3 program in the U.S. and E.U. aimed at demonstrating comparative safety, efficacy and immunogenicity in diabetes mellitus patients.
“This study clearly demonstrates that Biocon’s Insulin Glargine is bioequivalent to LANTUS®, so that both insulins will have the same effect when used in identical doses”, said Dr Tim Heise, CEO Science & Administration of Profil® in Neuss, Germany, and Principal Investigator of the study.“The study had a robust design, was conducted under the international standards of ICH/GCP (International Conference of Harmonization/Good Clinical Practice) and used an automated euglycemic glucose clamp technique which is the gold standard for assessment of the pharmacodynamic properties of insulin preparations. Biocon’s Insulin Glargine and LANTUS® were very well tolerated; without any serious adverse event observed during the four month study period. I am very confident that based on these data, regulators will accept the pharamcokinetic and pharmacodynamic biosimilarity of Biocon’s Insulin Glargine and LANTUS®.”
"It doesn't matter how I answer that question. No one can really ever know, and you can't go back. You can only move forward. She's healthy and happy. With proper attention to her diabetes, along with correct management of celiac, she can live a long, fulfilled life. Nothing I say will ever take that away." Dr. Alessio Fasano........
Background: Transplanting pancreatic islets is of significant interest for type 1 diabetes mellitus. After intraportal injection of islets, inferior engraftment and eventual loss of transplanted islets constitute major limitations.
WASHINGTON (Reuters) - U.S.drug reviewers on Tuesday said Roche Holding AG's eye drug Lucentis appeared to help diabetic patients with a vision-robbing eye condition, and raised few major issues about...
Nowhere is the American health care system more broken and desperate than rural Mississippi. Which is why an approach born in a broken and desperate place — Iran — may offer the best chance of saving lives.
Moving Forward with TrialNet My daughter looks exactly like my husband. There’s no argument from anyone when I say that – “Oh yeah, she looks just like him! Such a clone of Chris!” And this is fine with me, because I think they’re both cute. So my brown-eyed daughter, with the dark curly hair, looks slightly different than her blue-eyed mom. I forget that we don’t look anything alike, at times. Except when people in the grocery store stop me to tell me they love her bouncy ponytail with the ringlet curls, and I remember that she looks so much like her daddy. But what I can’t forget is that she’s made up of both of us. She may look like her dad, but she has her mother’s smile. (And her mother’s stubbornness … whoa boy.) And even if I want to ignore it, she also has a blend of her father and mother’s health histories swimming in her cells............
The addition of pramlintide, an analog of the naturally-occurring β-cell peptide amylin, before meals improves blood glucose control in patients with type 1 diabetes receiving insulin through an external closed-loop artificial pancreas system, according to a study published online June 18 in Diabetes Care....
The Friuli Venezia Giulia (FVG), a region of North Eastern Italy, has passed legislation (Decree No 2324/2010) to regulate the banking of umbilical cord blood samples for personal, autologous, or family-directed use, and to implement the Agreement of the State-Regions Permanent Conference (Decree No 62/CSR/2010). This paper aims to identify the formalities and the reasons why families collect and bank their cord blood in foreign banks for both personal and private use.
.........In particular, Walmart introduced today the low-cost ReliOn Prime meter and blood sugar test strips. The retailer will offer the ReliOn Prime meter for $16.24 and ReliOn Prime blood sugar test strips at $9 for 50-ct strips, or 18 cents per test. People with diabetes use meters and blood sugar test strips daily to test their blood sugar levels and determine when they need to take insulin
PHILADELPHIA – An algorithm based on hemoglobin A1c levels at admission was safe and effective in guiding diabetes therapy after discharge, based on a prospective, randomized pilot study of 224 inpatients with type 2 diabetes....
..."If we can do this at Grady hospital, a county hospital in downtown Atlanta, I think most of you can do it in your facilities. We see these patients within 2 weeks of discharge. I think frequent followup and education are key to [the success of] this type of program," Dr. Umpierrez said.
EndoGoddess V.2.0: Rewarding Healthy Behavior for Diabetics and Those that Care for Them. Project: Development and Clinical Trial.
The EndoGoddess App is a self-entry glucose journal that not only keeps patients healthier, but also enables them to earn rewards for healthy behavior. As most diabetics know, checking their glucose four times a day and writing it down to give to their doctor and keep track of their sugar levels is a complete drag, but it is very important to avoid emergency trips to the ER or worse yet, hypoglycemic shock and the fainting spells it can cause, which can be extremely dangerous. Our Application not only automates this recording and communication process, it also lets patients earn rewards for their good sugar tracking. No more paper journals!.....
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.